Kiniksa Pharmaceuticals International Plc (KNSA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 122,470 | 190,183 | 168,163 | 120,066 | 114,248 |
| Marketable Securities | 59,731 | 10,000 | 57,913 | 144,169 | 209,444 |
| Receivables | 3,985 | 3,224 | 2,551 | N/A | N/A |
| Inventories | 3,675 | 5,606 | 6,381 | 2,189 | N/A |
| TOTAL | $196,446 | $217,512 | $244,810 | $275,564 | $333,249 |
| Non-Current Assets | |||||
| PPE Net | 2,834 | 3,168 | 3,449 | 3,815 | 4,051 |
| Intangibles | 19,250 | 19,500 | 19,750 | 20,000 | 0 |
| Other Non-Current Assets | 14,270 | 12,679 | 11,199 | 11,779 | 12,164 |
| TOTAL | $36,354 | $35,347 | $34,398 | $35,594 | $16,215 |
| Total Assets | $232,800 | $252,859 | $279,208 | $311,158 | $349,464 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,868 | 1,649 | 4,156 | 2,763 | 503 |
| Accrued Expenses | 38,031 | 28,528 | 31,064 | 30,316 | 29,199 |
| Other current liabilities | 1,544 | 1,004 | 926 | N/A | 37 |
| TOTAL | $44,824 | $34,427 | $38,782 | $35,453 | $31,846 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 2,939 | 4,384 | 4,641 | 5,009 | 5,683 |
| TOTAL | $2,939 | $4,384 | $4,641 | $5,009 | $5,683 |
| Total Liabilities | $47,763 | $38,811 | $43,423 | $40,462 | $37,529 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 69,104 | 68,888 | 68,523 | 68,332 | 68,232 |
| Common Shares | 18 | 18 | 18 | 18 | 18 |
| Retained earnings | -675,397 | -639,064 | -608,520 | -566,957 | -517,473 |
| Other shareholders' equity | -66 | -45 | 27 | -21 | -34 |
| TOTAL | $185,037 | $214,048 | $235,785 | $270,696 | $311,935 |
| Total Liabilities And Equity | $232,800 | $252,859 | $279,208 | $311,158 | $349,464 |